Antibodies, ISSN 2073-4468, 04/2019, Volume 8, Issue 2, p. 30
Activation of the humoral immune system is initiated when antibodies recognize an antigen and trigger effector functions through the interaction with Fc...
Neonates | Antigens | Immunoglobulins | Laboratories | Medical treatment | Immunoglobulin G | Antibodies | Cytotoxicity | Glycosylation | Immune response (humoral) | Complement component C1 | Fc receptors | Receptors | Immunotherapy | Ligands | Autoimmune diseases | Immune system | IgG | allotypes | glycosylation | Fc effector molecules
Neonates | Antigens | Immunoglobulins | Laboratories | Medical treatment | Immunoglobulin G | Antibodies | Cytotoxicity | Glycosylation | Immune response (humoral) | Complement component C1 | Fc receptors | Receptors | Immunotherapy | Ligands | Autoimmune diseases | Immune system | IgG | allotypes | glycosylation | Fc effector molecules
Journal Article
Trends in Immunology, ISSN 1471-4906, 2016, Volume 37, Issue 3, pp. 221 - 232
The identification of multiple broadly neutralizing antibodies (bNAbs) against the HIV-1 envelope glycoprotein (Env) trimer has facilitated its structural...
Allergy and Immunology | B-CELL RECEPTORS | PROXIMAL EXTERNAL-REGION | CONFORMATIONAL EPITOPE | GLYCOPROTEIN TRIMERS | AFFINITY MATURATION | CRYSTAL-STRUCTURE | IMMUNODEFICIENCY-VIRUS TYPE-1 | BINDING-SITE | IMMUNOGEN DESIGN | IMMUNOLOGY | DEPENDENT EPITOPE | Antibodies, Neutralizing | Epitope Mapping | HIV Infections - immunology | HIV Infections - prevention & control | HIV-1 - immunology | Animals | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Protein Multimerization | AIDS Vaccines - immunology | Disease Models, Animal | Antigens | Development and progression | Immunization | HIV (Viruses) | Analysis | Proteins | Immunoglobulins | Viruses | Infections | Vaccines | Viral infections | Binding sites | HIV-1 vaccine development | Immunogen design | Native-like trimers | Broadly neutralizing antibodies
Allergy and Immunology | B-CELL RECEPTORS | PROXIMAL EXTERNAL-REGION | CONFORMATIONAL EPITOPE | GLYCOPROTEIN TRIMERS | AFFINITY MATURATION | CRYSTAL-STRUCTURE | IMMUNODEFICIENCY-VIRUS TYPE-1 | BINDING-SITE | IMMUNOGEN DESIGN | IMMUNOLOGY | DEPENDENT EPITOPE | Antibodies, Neutralizing | Epitope Mapping | HIV Infections - immunology | HIV Infections - prevention & control | HIV-1 - immunology | Animals | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Protein Multimerization | AIDS Vaccines - immunology | Disease Models, Animal | Antigens | Development and progression | Immunization | HIV (Viruses) | Analysis | Proteins | Immunoglobulins | Viruses | Infections | Vaccines | Viral infections | Binding sites | HIV-1 vaccine development | Immunogen design | Native-like trimers | Broadly neutralizing antibodies
Journal Article
Cell, ISSN 0092-8674, 12/2015, Volume 163, Issue 7, pp. 1702 - 1715
The envelope glycoprotein trimer mediates HIV-1 entry into cells. The trimer is flexible, fluctuating between closed and more open conformations and sometimes...
NEUTRALIZING ANTIBODY-RESPONSE | DESIGN | AFFINITY MATURATION | CRYSTAL-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GLYCOPROTEIN COMPLEX | GP41 | ENV TRIMERS | GP120 | QUATERNARY | REGION | CELL BIOLOGY | Antibodies, Neutralizing | HIV-1 | Rabbits | HIV Envelope Protein gp41 - genetics | Immunoglobulin G - chemistry | AIDS Vaccines - immunology | Models, Molecular | HIV Envelope Protein gp41 - chemistry | AIDS Vaccines - chemistry | Animals | Mutagenesis | Hydrophobic and Hydrophilic Interactions | Protein Conformation | Epitopes - chemistry | env Gene Products, Human Immunodeficiency Virus - chemistry | HIV (Viruses) | AIDS vaccines | Antigenic determinants | Viral antibodies | Antibodies
NEUTRALIZING ANTIBODY-RESPONSE | DESIGN | AFFINITY MATURATION | CRYSTAL-STRUCTURE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GLYCOPROTEIN COMPLEX | GP41 | ENV TRIMERS | GP120 | QUATERNARY | REGION | CELL BIOLOGY | Antibodies, Neutralizing | HIV-1 | Rabbits | HIV Envelope Protein gp41 - genetics | Immunoglobulin G - chemistry | AIDS Vaccines - immunology | Models, Molecular | HIV Envelope Protein gp41 - chemistry | AIDS Vaccines - chemistry | Animals | Mutagenesis | Hydrophobic and Hydrophilic Interactions | Protein Conformation | Epitopes - chemistry | env Gene Products, Human Immunodeficiency Virus - chemistry | HIV (Viruses) | AIDS vaccines | Antigenic determinants | Viral antibodies | Antibodies
Journal Article
PLoS pathogens, ISSN 1553-7366, 2015, Volume 11, Issue 3, pp. 1 - 22
The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly neutralizing antibodies (bNAbs) to protect against HIV-1...
MICROBIOLOGY | DEPENDENT EPITOPE | GP41-GP120 INTERFACE | POTENT | VIROLOGY | BROADLY NEUTRALIZING ANTIBODIES | GLYCOPROTEIN COMPLEX | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENV TRIMERS | BINDING-SITE | CD4 BINDING | MONOCLONAL-ANTIBODIES | PARASITOLOGY | Epitope Mapping | Gene Products, env - immunology | HIV Antibodies - chemistry | Epitopes - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | HIV Antigens - immunology | Gene Products, env - chemistry | HIV-1 - chemistry | Antibodies, Neutralizing - chemistry | HIV Antigens - chemistry | Epitopes - chemistry | Competition | Acquired immune deficiency syndrome | Microscopy | AIDS | Vaccines | Grants | Experiments
MICROBIOLOGY | DEPENDENT EPITOPE | GP41-GP120 INTERFACE | POTENT | VIROLOGY | BROADLY NEUTRALIZING ANTIBODIES | GLYCOPROTEIN COMPLEX | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENV TRIMERS | BINDING-SITE | CD4 BINDING | MONOCLONAL-ANTIBODIES | PARASITOLOGY | Epitope Mapping | Gene Products, env - immunology | HIV Antibodies - chemistry | Epitopes - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | HIV Antigens - immunology | Gene Products, env - chemistry | HIV-1 - chemistry | Antibodies, Neutralizing - chemistry | HIV Antigens - chemistry | Epitopes - chemistry | Competition | Acquired immune deficiency syndrome | Microscopy | AIDS | Vaccines | Grants | Experiments
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2015, Volume 112, Issue 38, pp. 11947 - 11952
A key challenge in the quest toward an HIV-1 vaccine is design of immunogens that can generate a broadly neutralizing antibody (bnAb) response against the...
Antigenic diversity | HIV-1 envelope | Clade C trimers | HIV immunogens | Neutralizing antibodies | ANTIBODIES | clade C trimers | RECOGNITION | antigenic diversity | MULTIDISCIPLINARY SCIENCES | neutralizing antibodies | VULNERABILITY | GP120 | QUATERNARY | IMMUNODEFICIENCY-VIRUS TYPE-1 | CRYO-EM STRUCTURE | Temperature | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Protein Multimerization | Solubility | Models, Molecular | Negative Staining | Cryoelectron Microscopy | HIV-1 - immunology | HIV Antigens - immunology | Immunoglobulin Fab Fragments - chemistry | Drug Design | HIV Antigens - chemistry | Immunoglobulin Fab Fragments - immunology | Protein Stability | env Gene Products, Human Immunodeficiency Virus - chemistry | Complications and side effects | Care and treatment | Immunogenetics | Disease transmission | Analysis | Research | Vaccines | HIV infection | Health aspects | Biological Sciences
Antigenic diversity | HIV-1 envelope | Clade C trimers | HIV immunogens | Neutralizing antibodies | ANTIBODIES | clade C trimers | RECOGNITION | antigenic diversity | MULTIDISCIPLINARY SCIENCES | neutralizing antibodies | VULNERABILITY | GP120 | QUATERNARY | IMMUNODEFICIENCY-VIRUS TYPE-1 | CRYO-EM STRUCTURE | Temperature | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Protein Multimerization | Solubility | Models, Molecular | Negative Staining | Cryoelectron Microscopy | HIV-1 - immunology | HIV Antigens - immunology | Immunoglobulin Fab Fragments - chemistry | Drug Design | HIV Antigens - chemistry | Immunoglobulin Fab Fragments - immunology | Protein Stability | env Gene Products, Human Immunodeficiency Virus - chemistry | Complications and side effects | Care and treatment | Immunogenetics | Disease transmission | Analysis | Research | Vaccines | HIV infection | Health aspects | Biological Sciences
Journal Article
Immunity, ISSN 1074-7613, 06/2017, Volume 46, Issue 6, pp. 1073 - 1088.e6
The development of stabilized recombinant HIV envelope trimers that mimic the virion surface molecule has increased enthusiasm for a neutralizing antibody...
rhesus macaques | NFL | Tfh cells | BG505 | HIV vaccine | SOSIP | germinal centers | GC B cells | nonhuman primates | protein design | TARGET | STANDARDIZED ASSESSMENTS | DESIGN | TFH CELLS | GLYCOPROTEIN COMPLEX | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENV TRIMERS | IMMUNOLOGY | ESCAPE | Immunization | env Gene Products, Human Immunodeficiency Virus - immunology | Epitopes, B-Lymphocyte - chemistry | Germinal Center - immunology | Humans | Protein Multimerization | AIDS Vaccines - immunology | Cells, Cultured | Epitopes, B-Lymphocyte - immunology | HIV Infections - immunology | HIV-1 - immunology | Animals | Antibodies, Neutralizing - therapeutic use | Germinal Center - virology | Injections, Subcutaneous | HIV Infections - therapy | Primates | HIV Antibodies - therapeutic use | env Gene Products, Human Immunodeficiency Virus - chemistry | Antigens | AIDS vaccines | Usage | Analysis | Development and progression | HIV (Viruses) | B cells | Immunoglobulins | Trimers | Vaccines | Lymph nodes | Design | Human immunodeficiency virus--HIV | Neutralizing | Reaction kinetics | Monoclonal antibodies | Robustness | Mutation | Kinetics | Recombinant | Lymph | Resource
rhesus macaques | NFL | Tfh cells | BG505 | HIV vaccine | SOSIP | germinal centers | GC B cells | nonhuman primates | protein design | TARGET | STANDARDIZED ASSESSMENTS | DESIGN | TFH CELLS | GLYCOPROTEIN COMPLEX | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENV TRIMERS | IMMUNOLOGY | ESCAPE | Immunization | env Gene Products, Human Immunodeficiency Virus - immunology | Epitopes, B-Lymphocyte - chemistry | Germinal Center - immunology | Humans | Protein Multimerization | AIDS Vaccines - immunology | Cells, Cultured | Epitopes, B-Lymphocyte - immunology | HIV Infections - immunology | HIV-1 - immunology | Animals | Antibodies, Neutralizing - therapeutic use | Germinal Center - virology | Injections, Subcutaneous | HIV Infections - therapy | Primates | HIV Antibodies - therapeutic use | env Gene Products, Human Immunodeficiency Virus - chemistry | Antigens | AIDS vaccines | Usage | Analysis | Development and progression | HIV (Viruses) | B cells | Immunoglobulins | Trimers | Vaccines | Lymph nodes | Design | Human immunodeficiency virus--HIV | Neutralizing | Reaction kinetics | Monoclonal antibodies | Robustness | Mutation | Kinetics | Recombinant | Lymph | Resource
Journal Article
Journal of virology, ISSN 0022-538X, 2015, Volume 89, Issue 20, pp. 10383 - 10398
Generating neutralizing antibodies (nAbs) is a major goal of many current HIV-1 vaccine efforts. To be of practical value, these nAbs must be both potent and...
CENTER B-CELLS | MUCOSAL SHIV CHALLENGE | POTENT | VIROLOGY | GLYCOPROTEIN TRIMERS | BROADLY NEUTRALIZING ANTIBODIES | VACCINE | IMMUNODEFICIENCY-VIRUS TYPE-1 | FOLLICULAR HELPER-CELL | GERMINAL CENTER | MONOCLONAL-ANTIBODIES | Antibody Specificity | Epitope Mapping | HIV Infections - prevention & control | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Protein Multimerization | Epitopes - immunology | HIV Infections - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | Immunoglobulin G - biosynthesis | HIV-1 - chemistry | Receptors, Antigen, B-Cell - chemistry | HEK293 Cells | Protein Engineering | HIV Antibodies - biosynthesis | env Gene Products, Human Immunodeficiency Virus - chemistry | Gene Expression | Immunization | HIV Infections - virology | Immunoglobulin G - chemistry | Solubility | Models, Molecular | Recombinant Proteins - chemistry | Antigens, Viral - chemistry | Recombinant Proteins - genetics | HIV-1 - genetics | HIV Antibodies - chemistry | Receptors, Antigen, B-Cell - immunology | Recombinant Proteins - administration & dosage | Antigens, Viral - immunology | HIV-1 - immunology | Animals | B-Lymphocytes - immunology | Recombinant Proteins - immunology | Antibodies, Neutralizing - biosynthesis | Antibodies, Neutralizing - chemistry | env Gene Products, Human Immunodeficiency Virus - administration & dosage | Protein Binding | Epitopes - chemistry | Mice
CENTER B-CELLS | MUCOSAL SHIV CHALLENGE | POTENT | VIROLOGY | GLYCOPROTEIN TRIMERS | BROADLY NEUTRALIZING ANTIBODIES | VACCINE | IMMUNODEFICIENCY-VIRUS TYPE-1 | FOLLICULAR HELPER-CELL | GERMINAL CENTER | MONOCLONAL-ANTIBODIES | Antibody Specificity | Epitope Mapping | HIV Infections - prevention & control | env Gene Products, Human Immunodeficiency Virus - immunology | Humans | Protein Multimerization | Epitopes - immunology | HIV Infections - immunology | env Gene Products, Human Immunodeficiency Virus - genetics | Immunoglobulin G - biosynthesis | HIV-1 - chemistry | Receptors, Antigen, B-Cell - chemistry | HEK293 Cells | Protein Engineering | HIV Antibodies - biosynthesis | env Gene Products, Human Immunodeficiency Virus - chemistry | Gene Expression | Immunization | HIV Infections - virology | Immunoglobulin G - chemistry | Solubility | Models, Molecular | Recombinant Proteins - chemistry | Antigens, Viral - chemistry | Recombinant Proteins - genetics | HIV-1 - genetics | HIV Antibodies - chemistry | Receptors, Antigen, B-Cell - immunology | Recombinant Proteins - administration & dosage | Antigens, Viral - immunology | HIV-1 - immunology | Animals | B-Lymphocytes - immunology | Recombinant Proteins - immunology | Antibodies, Neutralizing - biosynthesis | Antibodies, Neutralizing - chemistry | env Gene Products, Human Immunodeficiency Virus - administration & dosage | Protein Binding | Epitopes - chemistry | Mice
Journal Article
Journal of experimental medicine, ISSN 0022-1007, 2017, Volume 214, Issue 9, pp. 2573 - 2590
Induction of broadly neutralizing antibodies (bNAbs) by HIV-1 envelope glycoprotein immunogens would be a major advance toward an effective vaccine. A critical...
VACCINE DEVELOPMENT | MEDICINE, RESEARCH & EXPERIMENTAL | POTENT | GERMLINE PRECURSORS | RECOGNITION | AFFINITY MATURATION | IMMUNODEFICIENCY-VIRUS TYPE-1 | B-CELL-LINEAGE | BINDING-SITE | IMMUNOGEN DESIGN | IMMUNOLOGY | MONOCLONAL-ANTIBODIES | Protein Structure, Tertiary | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | Humans | HEK293 Cells | Protein Multimerization - immunology | Crystallography, X-Ray | HIV Envelope Protein gp160 - immunology | Mice | Gene Knock-In Techniques | Immunization | Immunoglobulins | Secretion | Glycoprotein | Reengineering | Antibodies | T cell receptors | Activation | Vaccines | CD4 antigen | Cell activation | Lymphocytes B | Neutralizing | Human immunodeficiency virus--HIV | Binding sites | Crystal structure | Conformation | 312
VACCINE DEVELOPMENT | MEDICINE, RESEARCH & EXPERIMENTAL | POTENT | GERMLINE PRECURSORS | RECOGNITION | AFFINITY MATURATION | IMMUNODEFICIENCY-VIRUS TYPE-1 | B-CELL-LINEAGE | BINDING-SITE | IMMUNOGEN DESIGN | IMMUNOLOGY | MONOCLONAL-ANTIBODIES | Protein Structure, Tertiary | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | Humans | HEK293 Cells | Protein Multimerization - immunology | Crystallography, X-Ray | HIV Envelope Protein gp160 - immunology | Mice | Gene Knock-In Techniques | Immunization | Immunoglobulins | Secretion | Glycoprotein | Reengineering | Antibodies | T cell receptors | Activation | Vaccines | CD4 antigen | Cell activation | Lymphocytes B | Neutralizing | Human immunodeficiency virus--HIV | Binding sites | Crystal structure | Conformation | 312
Journal Article
Nature communications, ISSN 2041-1723, 2015, Volume 6, Issue 1, p. 8167
The recent identification of three broadly neutralizing antibodies (bnAbs) against gp120-gp41 interface epitopes has expanded the targetable surface on the...
PROXIMAL EXTERNAL-REGION | POTENT NEUTRALIZATION | BROAD NEUTRALIZATION | RECOGNITION | TRIMERS | MULTIDISCIPLINARY SCIENCES | ENVELOPE | VACCINE | BINDING-SITE | CRYO-EM STRUCTURE | DEPENDENT EPITOPE | Epitope Mapping | HIV Envelope Protein gp41 - immunology | Humans | Models, Molecular | Crystallography, X-Ray | Epitopes | Cryoelectron Microscopy | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | Immunoglobulin G - immunology | Computer Simulation | HEK293 Cells | Protein Conformation | Immunoglobulin Fab Fragments - immunology | Antibodies, Neutralizing | HIV-1 | Immunoglobulin G | HIV Antibodies | Biochemistry, Molecular Biology | HIV Envelope Protein gp120 | HIV Envelope Protein gp41 | Life Sciences | Biomolecules | Immunoglobulin Fab Fragments
PROXIMAL EXTERNAL-REGION | POTENT NEUTRALIZATION | BROAD NEUTRALIZATION | RECOGNITION | TRIMERS | MULTIDISCIPLINARY SCIENCES | ENVELOPE | VACCINE | BINDING-SITE | CRYO-EM STRUCTURE | DEPENDENT EPITOPE | Epitope Mapping | HIV Envelope Protein gp41 - immunology | Humans | Models, Molecular | Crystallography, X-Ray | Epitopes | Cryoelectron Microscopy | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | Immunoglobulin G - immunology | Computer Simulation | HEK293 Cells | Protein Conformation | Immunoglobulin Fab Fragments - immunology | Antibodies, Neutralizing | HIV-1 | Immunoglobulin G | HIV Antibodies | Biochemistry, Molecular Biology | HIV Envelope Protein gp120 | HIV Envelope Protein gp41 | Life Sciences | Biomolecules | Immunoglobulin Fab Fragments
Journal Article
Journal of biological chemistry, ISSN 0021-9258, 2019, Volume 294, Issue 15, pp. 5736 - 5746
HIV-1 entry into cells is mediated by the envelope glycoprotein (Env) and represents an attractive target for therapeutic intervention. Two drugs that inhibit...
inhibition mechanism | DOMAIN | human immunodeficiency virus (HIV) | 6-HELIX BUNDLE | BIOCHEMISTRY & MOLECULAR BIOLOGY | peptides | anchor inhibitor | TYPE-1 GP41 | EMERGENCE | ENFUVIRTIDE | PEPTIDE | membrane fusion | fusion peptide (FP) | fusion protein | antiviral drug | virus entry | RESISTANCE | INTERMEDIATE | drug resistance | MUTATIONS | PROMISCUOUS BINDING | Microbiology
inhibition mechanism | DOMAIN | human immunodeficiency virus (HIV) | 6-HELIX BUNDLE | BIOCHEMISTRY & MOLECULAR BIOLOGY | peptides | anchor inhibitor | TYPE-1 GP41 | EMERGENCE | ENFUVIRTIDE | PEPTIDE | membrane fusion | fusion peptide (FP) | fusion protein | antiviral drug | virus entry | RESISTANCE | INTERMEDIATE | drug resistance | MUTATIONS | PROMISCUOUS BINDING | Microbiology
Journal Article
11.
Full Text
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
Cell Reports, ISSN 2211-1247, 08/2017, Volume 20, Issue 8, pp. 1805 - 1817
The production of native-like recombinant versions of the HIV-1 envelope glycoprotein (Env) trimer requires overcoming the natural flexibility and instability...
TARGET | DISULFIDE BONDS | BROADLY NEUTRALIZING ANTIBODIES | GLYCOPROTEIN COMPLEX | GLYCOSYLATION | CRYO-EM STRUCTURE | CELL BIOLOGY
TARGET | DISULFIDE BONDS | BROADLY NEUTRALIZING ANTIBODIES | GLYCOPROTEIN COMPLEX | GLYCOSYLATION | CRYO-EM STRUCTURE | CELL BIOLOGY
Journal Article